FDA objects to CBD dietary supplement as uncertainty looms over substance
The U.S. Food and Drug Administration objected to an application from Charlotte’s Web Holdings Inc. for a CBD product to be sold as a dietary ingredient, leaving a cloud of uncertainty over the booming industry for the cannabis-derived substance. View the full article here: https://fortune.com/2021/08/11/fda-cbd-dietary-supplement-charlottes-web-holdings/ IASIC commends the FDA to sticking to science. While CBD